EUVIMED · CrossrefZeitschrift
Canada Communicable Disease Report
ISSN 1481-8531 · Infectious Disease and Control Branch (IDPCB) - Public Health Agency of Canada
Neueste Artikel
Summary of the National Advisory Committee on Immunization (NACI) Statement: Updated guidance for use of rabies vaccine for pre-exposure prophylaxis (PrEP)
Risk of tuberculosis (TB) disease in immigrants referred for post-landing TB medical surveillance: A retrospective cohort study in British Columbia, Canada
Epidemiology of invasive Haemophilus influenzae non-B in Newfoundland and Labrador: A retrospective case series of a clonal outbreak of serotype A (ST-23), 2020–2022
Invasive group A Streptococcus in Newfoundland and Labrador: Recent epidemiology and risk factors for severe infection
After the bite: A descriptive analysis of animal exposure incidents resulting in a human rabies post-exposure prophylaxis recommendation in Ontario, Canada, 2014–2024
Advancing wastewater surveillance through cross-border collaboration: A workshop summary
Intraseasonal waning of influenza vaccine effectiveness and implications for the optimal timing of seasonal vaccination programs: A scoping review
Changing case definition: An analysis of its impact on Lyme disease surveillance in Nova Scotia
Surveillance of laboratory exposures to human pathogens and toxins, Canada, 2024
Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2025–2026
First reported Canadian case of Trichophyton mentagrophytes genotype VII infection among men who have sex with men (MSM)
National hepatitis B and C estimates for 2021: Measuring Canada’s progress towards eliminating viral hepatitis as a public health concern
Assessing the impact of the COVID-19 pandemic on trends of select travel-acquired enteric illnesses in Canada
Summary of the mpox outbreak in Canada, April 28−December 31, 2022
The prevalence of HIV pre-exposure prophylaxis (HIV-PrEP) use and HIV-PrEP-to-need ratio in nine Canadian provinces, 2018–2021
Using behavioural science to improve antibiotic stewardship in Canadian long-term care homes: Protocol for a multi-center cluster randomized quality improvement study
Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2024–2025
Public health contributions of entomological surveillance of West Nile virus (WNV) and other mosquito-borne arboviruses in a context of climate change
Social capital interventions for human papillomavirus (HPV) immunization and cervical cancer screening: A rapid review
Invasive group A streptococcal disease surveillance in Canada, 2021–2022
Canadian laboratory incidents with human pathogens and toxins: An overview of reports, 2016–2022
Burden of disease of RSV in infants, children and pregnant women and people
Canadian vaccine safety surveillance reports following immunization with seasonal influenza vaccines, 2021–2022
Characteristics and clinical outcomes of nirmatrelvir/ritonavir (PaxlovidTM) recipients in Canada, 2022: a descriptive cohort study
Quantifying the economic gains associated with COVID-19 vaccination in the Canadian population: A cost-benefit analysis
Increased PrEP uptake and PrEP-RN coincide with decreased HIV diagnoses in men who have sex with men in Ottawa, Canada
Relative pandemic severity in Canada and four peer nations during the SARS-CoV-2 pandemic
Extensive SARS-CoV-2 testing reveals BA.1/BA.2 asymptomatic rates and underreporting in school children
Event-based surveillance: Providing early warning for communicable disease threats
Antibiotic prescribing and antimicrobial stewardship in long-term care facilities: Past interventions and implementation challenges
EUVIMED